Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers vol. 17, no. 23 (2025), p. 3728-3744
Autor principal: Resuli Blerina
Otros Autores: Walter, Julia, Kauffmann-Guerrero, Diego, Behr Jürgen, Arnold, Paola, Götschke Jeremias, Leuschner Gabriela, Kovács, Julia, Eze Chukwuka, Schneider, Christian, Tufman Amanda
Publicado:
MDPI AG
Materias:
Acceso en línea:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3280945880
003 UK-CbPIL
022 |a 2072-6694 
024 7 |a 10.3390/cancers17233728  |2 doi 
035 |a 3280945880 
045 2 |b d20250101  |b d20251231 
084 |a 231438  |2 nlm 
100 1 |a Resuli Blerina  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
245 1 |a Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany 
260 |b MDPI AG  |c 2025 
513 |a Journal Article 
520 3 |a Background: Lung cancer metastasis results from local invasion, loss of adhesion, migration, and distant implantation. Some small tumors metastasize diffusely other tumors progress to local bulky disease without metastasis. Here we compare these biologically divergent courses of progression and present an analysis of clinical features related to early diffuse metastasis vs. bulky disease. Methods: We retrospectively collected data from pathologically confirmed not-metastatic “bulky” (cT3-T4cN0cM0) or “diffusely metastatic” (cT1-T2cN1-3cM1) patients with lung cancer treated at our center from 2013 to 2023. Clinical data including sex, age, histology, ECOG-PS, tumor stage, smoking status, presence, and site of metastases, LDH, CRP, NLR ratio were collected. Results: A total of 375 patents with “bulky” (n = 95) or diffusely metastatic lung cancer (n = 280) were included in the analysis. In the univariate analysis, the diffusely metastatic population was younger (p = 0.001), had a higher proportion of never smokers (p = 0.02), histologically adenocarcinoma (p < 0.0001), TTF1 positive (p < 0.00001) and elevated baseline LDH in serum (LDH > 250U/l, p < 0.0001) compared to “bulky” population. Patients with diffuse metastatic disease presented worse OS (HR = 2.34, p = 0.0001) and PFS (HR = 6.89, p < 0.0001) compared to patients with bulky disease. Conclusions: Younger age, never smokers, TTF1 positivity, poorly differentiated tumors, adenocarcinoma histology were independently associated with risk of distant metastasis. 
653 |a Patients 
653 |a Histology 
653 |a Medical prognosis 
653 |a Metastasis 
653 |a Regression analysis 
653 |a Lung cancer 
653 |a Immunotherapy 
653 |a Age 
653 |a Cancer therapies 
653 |a Mutation 
653 |a Adenocarcinoma 
653 |a Biomarkers 
653 |a Tumors 
653 |a Biology 
653 |a Metastases 
653 |a Radiation therapy 
653 |a Chemotherapy 
653 |a Statistical analysis 
700 1 |a Walter, Julia  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
700 1 |a Kauffmann-Guerrero, Diego  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
700 1 |a Behr Jürgen  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
700 1 |a Arnold, Paola  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
700 1 |a Götschke Jeremias  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
700 1 |a Leuschner Gabriela  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
700 1 |a Kovács, Julia  |u Department of Thoracic Surgery Munich, University Hospital, LMU Munich, 80336 Munich, Germany 
700 1 |a Eze Chukwuka  |u Department of Radiation Oncology, University Hospital, LMU Munich, 80336 Munich, Germany 
700 1 |a Schneider, Christian  |u Department of Thoracic Surgery Munich, University Hospital, LMU Munich, 80336 Munich, Germany 
700 1 |a Tufman Amanda  |u Department of Medicine V, University Hospital, LMU Munich, Ziemssenstraße 1, 80336 München, Germany; julie.walter@gmx.de (J.W.); 
773 0 |t Cancers  |g vol. 17, no. 23 (2025), p. 3728-3744 
786 0 |d ProQuest  |t Biological Science Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3280945880/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text + Graphics  |u https://www.proquest.com/docview/3280945880/fulltextwithgraphics/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3280945880/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch